Drug recall
Apheresis Platelets, Platelet Additive Solution Added, Leukocytes Reduced
FDA recall event 88913 · Class II · OneBlood, Inc.
Key facts
| Event ID | 88913 |
|---|---|
| Recall numbers | B-0027-2022 |
| Recalling firm | OneBlood, Inc. |
| Product type | Biologics |
| Products | Apheresis Platelets, Platelet Additive Solution Added, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Plateletpheresis products, for which quality control for WBC count was not performed, were distributed. |
| Initiation date | Sep 21, 2021 |
| Report date | Nov 10, 2021 |
| Termination date | Nov 3, 2021 |
| City | St Petersburg |
| State | FL |
| Country | United States |
| FEI number | 1070196 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: